CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53
New England Journal of Medicine · 06.02.2025 · 392 (6) · 577-583
DOI: 10.1056/nejmoa2411507 ↗Kurz gefasst
Fallbericht in der Zeitschrift New England Journal of Medicine, erschienen am 06.02.2025. Verfasst von Karlo Perica und 25 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York. Hauptthemen laut MEDLINE: B-Cell Maturation Antigen, Immunotherapy, Adoptive, Lymphoma, T-Cell, Multiple Myeloma. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Leukemia and Lymphoma Society.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
- Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York.
- Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
- Department of Medicine, Weill Cornell Medical College, New York.
- Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York.
- Hematopathology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York.
ORCID-Profile: Ozgur Can Eren, Angelina Petrichenko, Jae H Park, Frederic D Bushman
Förderung
- NCI NIH HHS
- National Cancer Institute
- Leukemia and Lymphoma Society
Zitieren
APA
Perica, K., Jain, N., Scordo, M., Patel, R., Eren, O. C., Patel, U., Gundem, G., Domenico, D., Mitra, S., Socci, N. D., Everett, J. K., Roche, A. M., Petrichenko, A., Shah, G. L., Arcila, M. E., Borsu, L., Park, J. H., Horwitz, S. M., Giralt, S. A., …, & Mailankody, S. (2025). CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53. New England Journal of Medicine, 392(6), 577-583. https://doi.org/10.1056/nejmoa2411507
Vancouver
Perica K, Jain N, Scordo M, Patel R, Eren OC, Patel U, et al. CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53. New England Journal of Medicine. 2025;392(6):577-583. doi:10.1056/nejmoa2411507
BibTeX
@article{Perica2025,
author = {Perica, Karlo and Jain, Nayan and Scordo, Michael and Patel, Ruchi and Eren, Ozgur Can and Patel, Utsav and Gundem, Gunes and Domenico, Dylan and Mitra, Sneha and Socci, Nicholas D and Everett, John K and Roche, Aoife M and Petrichenko, Angelina and Shah, Gunjan L and Arcila, Maria E and Borsu, Laetitia and Park, Jae H and Horwitz, Steven M and Giralt, Sergio A and Dogan, Ahmet and Leslie, Christina and Papaemmanuil, Elli and Bushman, Frederic D and Usmani, Saad Z and Sadelain, Michel and Mailankody, Sham},
title = {CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {6},
pages = {577--583},
doi = {10.1056/nejmoa2411507}
}
EUVIMED